Ken Fisher Blueprint Medicines Corp Transaction History
Fisher Asset Management, LLC
- $213 Billion
- Q1 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Fisher Asset Management, LLC holds 335,128 shares of BPMC stock, worth $35.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
335,128
Previous 326,664
2.59%
Holding current value
$35.4 Million
Previous $30.1 Million
5.51%
% of portfolio
0.01%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding BPMC
# of Institutions
314Shares Held
60.6MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$681 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$666 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$660 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$441 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$264 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.3B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...